Target intelligence / Profile preview

RNA, U6 small nuclear 602, pseudogene (RNU6-602P)

Target
RNU6-602P
Molecular classification
Other (pseudogene of non-coding RNA; specifically a small nuclear RNA pseudogene)
01

Overview

RNA, U6 small nuclear 602, pseudogene (RNU6-602P) is a processed pseudogene of the U6 small nuclear RNA family in the human genome[1][3][5][7]. It is not a protein-coding gene, nor does it encode a functional small nuclear RNA involved in the spliceosome. Instead, RNU6-602P is a product of retrotransposition events that do not produce an active transcript capable of participating in RNA splicing. Unlike functional U6 snRNA, which is a core component of the spliceosome complex essential for pre-mRNA splicing in eukaryotes, this pseudogene is generally regarded as nonfunctional in direct biological processes. However, emerging research suggests that some RNA pseudogenes can have regulatory functions—such as acting as miRNA sponges, generating endo-siRNAs, or being transcribed into noncoding RNAs with possible regulatory impact—but such functions have not specifically been established for RNU6-602P[2][4][6]. Thus, RNU6-602P is best described as a genomic remnant of an RNA gene, without known drug interaction or therapeutic relevance, and is not considered a druggable or classical molecular target[3][6][7].

Other names
RNU6-602PRNA, U6 small nuclear 602, pseudogene
02

Mechanism of action

None

03

Biological functions

None known for the pseudogene; parental U6 snRNA is involved in pre-mRNA splicing as a component of the spliceosome, but the pseudogene itself is considered nonfunctional in splicing
04

Disease associations

Other (pseudogenes can sometimes play regulatory roles, such as acting as competitive endogenous RNAs or involvement in chromatin remodeling, but there is no evidence that RNU6-602P specifically is implicated in disease)

Beyond the preview

Go deeper on RNA, U6 small nuclear 602, pseudogene (RNU6-602P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 602, pseudogene (RNU6-602P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call